1. Home
  2. LEGH vs OMER Comparison

LEGH vs OMER Comparison

Compare LEGH & OMER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LEGH

Legacy Housing Corporation (TX)

HOLD

Current Price

$22.09

Market Cap

528.7M

ML Signal

HOLD

Logo Omeros Corporation

OMER

Omeros Corporation

HOLD

Current Price

$12.19

Market Cap

772.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LEGH
OMER
Founded
2005
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
528.7M
772.8M
IPO Year
2018
2008

Fundamental Metrics

Financial Performance
Metric
LEGH
OMER
Price
$22.09
$12.19
Analyst Decision
Buy
Strong Buy
Analyst Count
3
5
Target Price
$25.00
$32.50
AVG Volume (30 Days)
63.0K
1.2M
Earning Date
05-08-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
98.15
EPS
0.46
0.62
Revenue
$164,567,000.00
$29,868,000.00
Revenue This Year
$11.90
N/A
Revenue Next Year
$6.58
$233.22
P/E Ratio
$49.17
$21.46
Revenue Growth
N/A
N/A
52 Week Low
$18.29
$2.95
52 Week High
$29.45
$17.65

Technical Indicators

Market Signals
Indicator
LEGH
OMER
Relative Strength Index (RSI) 53.09 37.56
Support Level $20.53 $10.82
Resistance Level $22.46 $13.00
Average True Range (ATR) 1.01 0.74
MACD 0.05 -0.31
Stochastic Oscillator 49.41 11.65

Price Performance

Historical Comparison
LEGH
OMER

About LEGH Legacy Housing Corporation (TX)

Legacy Housing Corp builds, sells, and finances manufactured homes and tiny houses that are distributed through a network of independent retailers and company-owned stores, and are also sold directly to manufactured home communities. The Company manufactures and provides for the transport of manufactured homes, provides wholesale financing to dealers and mobile home parks, provides retail financing to consumers, and is involved in financing and developing new manufactured home communities. The Company manufactures its mobile homes at plants in Fort Worth, Texas; Commerce, Texas; and Eatonton, Georgia. The Company also sells homes directly to consumers, through its own retail stores, and to dealers and mobile home parks.

About OMER Omeros Corporation

Omeros Corp is a United States-based clinical-stage biopharmaceutical company engaged in discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting immunologic disorders including complement-mediated diseases, cancers, and addictive and compulsive disorders. The drug candidate in the pipeline of complement-targeted therapeutics is narsoplimab (OMS721), a proprietary, patented human monoclonal antibody targeting mannan-binding lectin-associated serine protease 2, the key activator of the lectin pathway of complement. Clinical development of narsoplimab is currently focused on hematopoietic stem cell transplant-associated thrombotic microangiopathy and immunoglobulin nephropathy.

Share on Social Networks: